Currently out of the existing stock ratings of Gregory Fraser, 50 are a BUY (90.91%), 5 are a HOLD (9.09%).

Gregory Fraser

Work Performance Price Targets & Ratings Chart

Analyst Gregory Fraser, carries an average stock price target met ratio of 49.04% that have a potential upside of 36.1% achieved within 194 days. Previously, Gregory Fraser worked at TRUIST.

Gregory Fraser’s has documented 110 price targets and ratings displayed on 19 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 06-Mar-2025.

Wall Street Analyst Gregory Fraser

Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.

Average potential price target upside

CRXT Clarus Therapeutics Holdings OSMT Osmotica Pharmaceuticals plc BDSI BioDelivery Sciences International NVCR Novocure Ltd ANIP ANI Pharmaceuticals CORT Corcept Therapeutics EOLS Evolus XAIR Beyond Air BHC Bausch Health Companies AERI Aerie Pharmaceuticals RVLP RVL Pharmaceuticals PLC AMRX Amneal Pharmaceuticals, Common Stock ARQT Arcutis Biotherapeutics  BTMD biote Corp JAZZ Jazz Pharmaceuticals PLC AER AerCap Holdings NV CR Crane Company OS OneStream, Common Stock PCRX Pacira Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Oct-2021

$3

4 years 22 days ago
(23-Aug-2022)

0/2 (0%)

$2.55 (566.67%)

Hold Since 22-Aug-2022

$13

4 years 23 days ago
(22-Aug-2022)

0/1 (0%)

$8.7 (202.33%)

Buy Since 14-Oct-2021

$10

4 years 3 months 28 days ago
(17-May-2022)

0/1 (0%)

$4.78 (91.57%)

Buy Since 20-Sep-2021

$12

$11.98 (59900.00%)

4 years 11 months 25 days ago
(20-Sep-2021)

0/1 (0%)

$3.86 (47.42%)

Buy Since 20-Sep-2021

$20

$19.98 (99900.00%)

4 years 11 months 25 days ago
(20-Sep-2021)

0/1 (0%)

$11.86 (145.70%)

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?